Akzo Nobel N.V. AKZOF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.49B | 11.54B | 11.51B | 11.47B | 11.50B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.49B | 11.54B | 11.51B | 11.47B | 11.50B |
| Cost of Revenue | 6.72B | 6.74B | 6.75B | 6.76B | 6.78B |
| Gross Profit | 4.77B | 4.80B | 4.76B | 4.71B | 4.72B |
| SG&A Expenses | 3.44B | 3.41B | 3.38B | 3.34B | 3.36B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -11.74M | -6.80M | -11.39M | -6.83M | 319.02M |
| Total Operating Expenses | 10.46B | 10.47B | 10.44B | 10.41B | 10.78B |
| Operating Income | 1.03B | 1.07B | 1.07B | 1.06B | 720.80M |
| Income Before Tax | 1.18B | 1.18B | 1.13B | 1.14B | 370.03M |
| Income Tax Expenses | 385.67M | 405.79M | 377.80M | 373.32M | 273.24M |
| Earnings from Continuing Operations | 795.49 | 774.78 | 754.70 | 763.86 | 96.79 |
| Earnings from Discontinued Operations | -2.31M | -2.33M | -1.17M | -1.17M | -1.17M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -31.44M | -32.65M | -34.66M | -40.04M | -46.71M |
| Net Income | 761.73M | 739.80M | 718.86M | 722.65M | 48.91M |
| EBIT | 1.03B | 1.07B | 1.07B | 1.06B | 720.80M |
| EBITDA | 1.47B | 1.51B | 1.51B | 1.49B | 1.13B |
| EPS Basic | 4.45 | 4.32 | 4.20 | 4.22 | 0.29 |
| Normalized Basic EPS | 2.80 | 2.77 | 2.77 | 2.73 | 1.61 |
| EPS Diluted | 4.44 | 4.30 | 4.18 | 4.20 | 0.27 |
| Normalized Diluted EPS | 2.79 | 2.76 | 2.75 | 2.71 | 1.59 |
| Average Basic Shares Outstanding | 685.10M | 684.70M | 684.30M | 683.90M | 683.60M |
| Average Diluted Shares Outstanding | 687.07M | 686.67M | 687.28M | 687.64M | 690.80M |
| Dividend Per Share | 1.79 | 1.79 | 2.29 | 2.29 | 2.14 |
| Payout Ratio | 48.55% | 52.85% | 53.34% | 53.45% | 814.99% |